HEATHER PICKETT: Open Payments
NPI 1528231123 · STAFFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 18 payments from 7 companies in 2025. Trend: 2023 $228 · 2024 $506 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $110 |
| Novo Nordisk Inc | 3 | $83 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $70 |
| Exeltis, USA Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $18 |
Products named: Veozah, SLYND, ZEPBOUND, Wegovy, Ozempic, GEMTESA, EVENITY.
Industry payments across VA — which companies pay providers there.
